Arizona Pulmonary Specialists

Phoenix, Arizona 85013

2 studies enrolling now · 21 studies all time

What they study most

Acute Interstitial Pneumonitis, Cardiovascular Diseases, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Cryptogenic Organizing Pneumonia, Desquamative Interstitial Pneumonia, Emphysema, Fibrosis, Idiopathic Interstitial Pneumonia, Idiopathic Lymphoid Interstitial Pneumonia, Idiopathic Pleuroparenchymal Fibroelastosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Studies at this site

• A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) — Recruiting now
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of Mosliciguat in PH-ILD — Running, not enrolling
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT — Completed
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) — Completed
• Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed
• Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study) — Completed
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis — Status unconfirmed
• Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) — Completed
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Study of Ambrisentan in Participants With Pulmonary Hypertension — Completed
• PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) — Stopped early
• Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill — Completed
• Remodulin® to Oral Treprostinil Transition — Completed
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early
• Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) — Completed
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) — Completed